Receives 'zero' 483 observations
Vivimed Labs announced that the Company's API manufacturing facility located in Sant Celoni, Spain was recently inspected by the USFDA in compliance with their requirements. At the end of the successful inspection, 'zero' 483 observations were issued.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
